ENOXAPARIN Drug Patent Profile
✉ Email this page to a colleague
When do Enoxaparin patents expire, and when can generic versions of Enoxaparin launch?
Enoxaparin is a drug marketed by Amphastar Pharms Inc, Emerge Bioscience, Sandoz Inc, Amphastar Pharm, Be Pharms, Gland, Hebei Changshan, Sandoz, Shenzhen Techdow, and Zydus Pharms. and is included in eleven NDAs.
The generic ingredient in ENOXAPARIN is enoxaparin sodium. There are thirteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the enoxaparin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Enoxaparin
A generic version of ENOXAPARIN was approved as enoxaparin sodium by SANDOZ INC on November 28th, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ENOXAPARIN?
- What are the global sales for ENOXAPARIN?
- What is Average Wholesale Price for ENOXAPARIN?
Summary for ENOXAPARIN
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Drug Prices: | Drug price information for ENOXAPARIN |
| DailyMed Link: | ENOXAPARIN at DailyMed |
US Patents and Regulatory Information for ENOXAPARIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 077857-004 | Jul 23, 2010 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hebei Changshan | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 218775-001 | Jan 7, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Shenzhen Techdow | ENOXAPARIN SODIUM (PRESERVATIVE FREE) | enoxaparin sodium | INJECTABLE;SUBCUTANEOUS | 205660-004 | Mar 15, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
